Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized observer-blind study of FLU NG versus Fluarix in older and younger adults
2008-004711-35Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of GSK2186877A and Fluarix in seasonal influenza (3 arms), sponsored by GSK. Primary endpoints: Influenza-specific CD4 T-cell frequency at Day 21, Superiority of FLU NG versus Fluarix in older adults and 1 more. Started Aug 2008; status: completed.
02
Drugs
GSK2186877AFluarix
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on 2008-004711-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004711-35.